| Rat paw volume in ml ± S.E.M (% inhibition) | ||||
---|---|---|---|---|---|
Groups | Day 0 | Day 7 | Day 14 | Day 21 | Day 28 |
Group I | 0.22 ± 0.05 | 0.25 ± 0.09 | 0.21 ± 0.05 | 0.22 ± 0.09 | 0.21 ± 0.08 |
Group II | 0.27 ± 0.03 | 0.82 ± 0.05 a* | 0.80 ± 0.09 a* | 0.71 ± 0.12 a* | 0.77 ± 0.09 a* |
Group III | 0.26 ± 0.01 (0.037%) | 0.53 ± 0.03 a*b* (35.36%) | 0.40 ± 0.05a* b* (50%) | 0.42 ± 0.05 a*b* (40.84%) | 0.38 ± 0.07 a#b* (50.64%) |
Group IV | 0.20 ± 0.07 | 0.23 ± 0.05 b* | 0.25 ± 0.01 b* | 0.26 ± 0.11 b* | 0.22 ± 0.03b* |
Group V | 0.26 ± 0.06 (0.037%) | 0.58 ± 0.04 a*b* (29.26%) | 0.48 ± 0.08 a*b* (40%) | 0.46 ± 0.09 a*b* (35.21%) | 0.42 ± 0.02 a*b* (45.45%) |
Group VI | 0.24 ± 0.08 (11.11%) | 0.62 ± 0.09 a*b* (24.39%) | 0.52 ± 0.09 a*b* (35%) | 0.52 ± 0.07 a*b* (26.76%) | 0.50 ± 0.04 a*b* (35.06%) |
Group VII | 0.25 ± 0.04 | 0.25 ± 0.08 b* | 0.26 ± 0.07 b* | 0.26 ± 0.05 b* | 0.21 ± 0.01b* |
Group VIII | 0.28 ± 0.09 (0.037%) | 0.54 ± 0.05 a*b# c@ (34.14%) | 0.50 ± 0.09 a*b* c# (37.5%) | 0.49 ± 0.04 a*b*c@ (30.98%) | 0.45 ± 0.11 a*b* (41.56%) |
Group IX | 0.24 ± 0.05 (11.11%) | 0.67 ± 0.11 a*b* (18.29%) | 0.54 ± 0.08 a* b* c@ (32.5%) | 0.52 ± 0.08 a*b* (26.76%) | 0.52 ± 0.10 a*b* (32.46%) |